{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:56:10Z","timestamp":1790546170310,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e32838","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T20:47:50Z","timestamp":1718311670000},"page":"e32838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Natural products can be potential inhibitors of metalloproteinase II from Bacteroides fragilis to intervene colorectal cancer"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6275-614X","authenticated-orcid":false,"given":"Bushra","family":"Arif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Yasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Qaiser","family":"Fatmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.heliyon.2024.e32838_bib1","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1200\/JCO.2010.28.2319","article-title":"Colorectal cancer epigenetics: complex simplicity","volume":"29","author":"Van Engeland","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib2","first-page":"19","article-title":"Genetic alterations in colorectal cancer","volume":"5","author":"Armaghany","year":"2012","journal-title":"Gastrointestinal cancer research: GCR"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41467-023-37229-x","article-title":"Blocking Dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e32838_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jprot.2015.05.037","article-title":"Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis","volume":"126","author":"Sethi","year":"2015","journal-title":"J. Proteonomics"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32838_bib5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/j.gastro.2008.07.076","article-title":"Genomic and epigenetic instability in colorectal cancer pathogenesis","volume":"135","author":"Grady","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32838_bib6","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA: a cancer journal for clinicians"},{"issue":"18","key":"10.1016\/j.heliyon.2024.e32838_bib7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/jnci\/djs346","article-title":"Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence","volume":"104","author":"Doubeni","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.heliyon.2024.e32838_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2147\/CIA.S109285","article-title":"Colorectal cancer development and advances in screening","volume":"11","author":"Simon","year":"2016","journal-title":"Clin. Interv. Aging"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32838_bib9","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","article-title":"Inflammation and colon cancer","volume":"138","author":"Terzi\u0107","year":"2010","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32838_bib10","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32838_bib11","doi-asserted-by":"crossref","first-page":"16365","DOI":"10.3390\/ijms140816365","article-title":"Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention","volume":"14","author":"Colussi","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e32838_bib12","series-title":"Inflammation and Cancer","first-page":"25","article-title":"The role of inflammation in colon cancer","author":"Janakiram","year":"2014"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32838_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1440-1746.2012.07200.x","article-title":"Molecular pathways in colorectal cancer","volume":"27","author":"Al\u2010Sohaily","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e32838_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/509348","article-title":"Genetic and epigenetic events generate multiple pathways in colorectal cancer progression","volume":"2012","author":"Pancione","year":"2012","journal-title":"Pathol. Res. Int."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32838_bib15","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ccell.2018.03.004","article-title":"The intestinal microbiota in colorectal cancer","volume":"33","author":"Tilg","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/J.ENG.2017.01.008","article-title":"The human microbiota in health and disease","volume":"3","author":"Wang","year":"2017","journal-title":"Engineering"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00432-018-2816-0","article-title":"Microbiota in cancer development and treatment","volume":"145","author":"Raza","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e32838_bib18","series-title":"Beneficial Microorganisms in Multicellular Life Forms","first-page":"323","article-title":"The hologenome concept","author":"Rosenberg","year":"2012"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e32838_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047075","article-title":"Species-level analysis of DNA sequence data from the NIH human microbiome project","volume":"7","author":"Conlan","year":"2012","journal-title":"PLoS One"},{"issue":"suppl_1","key":"10.1016\/j.heliyon.2024.e32838_bib20","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1111\/j.1753-4887.2012.00493.x","article-title":"Defining the human microbiome","volume":"70","author":"Ursell","year":"2012","journal-title":"Nutr. Rev."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32838_bib21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI76304","article-title":"Gut\/brain axis and the microbiota","volume":"125","author":"Mayer","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32838_bib22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/me.2014-1108","article-title":"Minireview: gut microbiota: the neglected endocrine organ","volume":"28","author":"Clarke","year":"2014","journal-title":"Mol. Endocrinol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32838_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn3071","article-title":"Gut feelings: the emerging biology of gut\u2013brain communication","volume":"12","author":"Mayer","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32838_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut\u2013brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/gbb.12109","article-title":"Microbial genes, brain & behaviour\u2013epigenetic regulation of the gut\u2013brain axis","volume":"13","author":"Stilling","year":"2014","journal-title":"Gene Brain Behav."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32838_bib26","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1038\/cti.2016.12","article-title":"Bugging inflammation: role of the gut microbiota","volume":"5","author":"Shen","year":"2016","journal-title":"Clinical & translational immunology"},{"key":"10.1016\/j.heliyon.2024.e32838_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fimmu.2020.00575","article-title":"Intestinal flora and disease mutually shape the regional immune system in the intestinal tract","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32838_bib28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32838_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/medsci6040116","article-title":"Microbiota in the gastrointestinal tract","volume":"6","author":"Dieterich","year":"2018","journal-title":"Med. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32838_bib30","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1128\/IAI.00187-08","article-title":"Bacteria in the intestine, helpful residents or enemies from within?","volume":"76","author":"Canny","year":"2008","journal-title":"Infect. Immun."},{"issue":"7402","key":"10.1016\/j.heliyon.2024.e32838_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","author":"Huttenhower","year":"2012","journal-title":"nature"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-016-0303-2","article-title":"Impact of the gut microbiota on inflammation, obesity, and metabolic disease","volume":"8","author":"Boulang\u00e9","year":"2016","journal-title":"Genome Med."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32838_bib33","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/nu4081095","article-title":"Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease","volume":"4","author":"Brown","year":"2012","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e32838_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2017.08.001","article-title":"Microbiota dysbiosis in select human cancers: evidence of association and causality","author":"Chen","year":"2017","journal-title":"Paper presented at the Seminars in immunology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32838_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrgastro.2015.25","article-title":"Microbiota organization\u2014a key to understanding CRC development","volume":"12","author":"Hold","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"29","key":"10.1016\/j.heliyon.2024.e32838_bib36","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.3748\/wjg.v20.i29.9716","article-title":"Inflammatory pathways in the early steps of colorectal cancer development","volume":"20","author":"Mariani","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1848158","article-title":"Gut Bacteroides species in health and disease","volume":"13","author":"Zafar","year":"2021","journal-title":"Gut Microb."},{"issue":"35","key":"10.1016\/j.heliyon.2024.e32838_bib38","doi-asserted-by":"crossref","first-page":"13099","DOI":"10.1073\/pnas.0804220105","article-title":"Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis","volume":"105","author":"Coyne","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32838_bib39","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1128\/JB.01519-07","article-title":"Expression of a uniquely regulated extracellular polysaccharide confers a large-capsule phenotype to Bacteroides fragilis","volume":"190","author":"Chatzidaki-Livanis","year":"2008","journal-title":"J. Bacteriol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e32838_bib40","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1073\/pnas.0608797104","article-title":"Phase-variable expression of a family of glycoproteins imparts a dynamic surface to a symbiont in its human intestinal ecosystem","volume":"104","author":"Fletcher","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2024.e32838_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2741\/3603","article-title":"Beneficial effects of Bacteroides fragilis polysaccharides on the immune system","volume":"15","author":"Troy","year":"2010","journal-title":"Frontiers in bioscience: J. Vis. Literacy"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32838_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.anaerobe.2011.05.017","article-title":"The human commensal Bacteroides fragilis binds intestinal mucin","volume":"17","author":"Huang","year":"2011","journal-title":"Anaerobe"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e32838_bib43","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1172\/JCI72334","article-title":"Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis","volume":"124","author":"Sears","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32838_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/ciu787","article-title":"The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients","volume":"60","author":"Boleij","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib45","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1186\/s12885-019-6115-1","article-title":"The association between fecal enterotoxigenic B. fragilis with colorectal cancer","volume":"19","author":"Haghi","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e32838_bib46","series-title":"Structural and Functional Diversity of Metalloproteinases Encoded by the Bacteroides Fragilis Pathogenicity Island","author":"Shiryaev","year":"2014"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32838_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat 3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32838_bib48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/mi.2016.53","article-title":"The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis","volume":"10","author":"Orberg","year":"2017","journal-title":"Mucosal Immunol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32838_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009056","article-title":"Strain diversity in the microbiome: lessons from Bacteroides fragilis","volume":"16","author":"Carrow","year":"2020","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32838_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158171","article-title":"Genomic diversity of enterotoxigenic strains of Bacteroides fragilis","volume":"11","author":"Pierce","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32838_bib51","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrg3456","article-title":"Functional and evolutionary implications of gene orthology","volume":"14","author":"Gabald\u00f3n","year":"2013","journal-title":"Nat. Rev. Genet."},{"issue":"D1","key":"10.1016\/j.heliyon.2024.e32838_bib52","doi-asserted-by":"crossref","first-page":"D687","DOI":"10.1093\/nar\/gky1080","article-title":"Vfdb 2019: a comparative pathogenomic platform with an interactive web interface","volume":"47","author":"Liu","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32838_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00889-14","article-title":"Revealing the bacterial butyrate synthesis pathways by analyzing (meta) genomic data","volume":"5","author":"Vital","year":"2014","journal-title":"mBio"},{"issue":"5\u20136","key":"10.1016\/j.heliyon.2024.e32838_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10735-009-9247-9","article-title":"Comparative analysis of an experimental subcellular protein localization assay and in silico prediction methods","volume":"40","author":"Hu","year":"2009","journal-title":"J. Mol. Histol."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e32838_bib55","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e32838_bib56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fchem.2020.00343","article-title":"Structure-based virtual screening: from classical to artificial intelligence","volume":"8","author":"Maia","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.heliyon.2024.e32838_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/srep46277","article-title":"Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors","volume":"7","author":"Lagorce","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/C8MD00472B","article-title":"ADMET-score\u2013a comprehensive scoring function for evaluation of chemical drug-likeness","volume":"10","author":"Guan","year":"2019","journal-title":"Medchemcomm"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32838_bib59","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","article-title":"ADMET modeling approaches in drug discovery","volume":"24","author":"Ferreira","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2024.e32838_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e32838_bib61","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e32838_bib62","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3390\/molecules27072089","article-title":"Computational identification of druggable bioactive compounds from catharanthus roseus and avicennia marina against colorectal cancer by targeting thymidylate synthase","volume":"27","author":"Islam","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32838_bib63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jsb.2011.09.006","article-title":"UCSF Chimera, MODELLER, and IMP: an integrated modeling system","volume":"179","author":"Yang","year":"2012","journal-title":"J. Struct. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32838_bib64","first-page":"246","article-title":"Paralog-divergent features may help reduce off-target effects of drugs: hints from glucagon subfamily analysis","volume":"15","author":"Sa","year":"2017","journal-title":"Dev. Reprod. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32838_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21315\/mjms2020.27.4.2","article-title":"The mechanism of Bacteroides fragilis toxin contributes to colon cancer formation","volume":"27","author":"Cheng","year":"2020","journal-title":"Malays. J. Med. Sci.: MJMS"},{"key":"10.1016\/j.heliyon.2024.e32838_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.626500","article-title":"Identification of protein subcellular localization with network and functional embeddings","volume":"11","author":"Pan","year":"2021","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32838_bib67","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1110\/ps.03479604","article-title":"Predicting subcellular localization of proteins for Gram\u2010negative bacteria by support vector machines based on n\u2010peptide compositions","volume":"13","author":"Yu","year":"2004","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32838_bib68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/bioinformatics\/btp002","article-title":"Properties and identification of human protein drug targets","volume":"25","author":"Bakheet","year":"2009","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32838_bib69","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1242\/jcs.03455","article-title":"Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and \u03b3-secretase-dependent E-cadherin cleavage","volume":"120","author":"Wu","year":"2007","journal-title":"J. Cell Sci."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32838_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113896","article-title":"Distinct interactions with cellular E-cadherin of the two virulent metalloproteinases encoded by a Bacteroides fragilis pathogenicity island","volume":"9","author":"Remacle","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32838_bib71","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/gut.44.4.504","article-title":"Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro","volume":"44","author":"Riegler","year":"1999","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e32838_bib72","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","article-title":"PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes","volume":"26","author":"Yu","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.heliyon.2024.e32838_bib73","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Combin. Chem."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32838_bib75","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e32838_bib76","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32838_bib77","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32838_bib78","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem: Chemistry Enabling Drug Discovery"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32838_bib79","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/jm0492002","article-title":"A bioavailability score","volume":"48","author":"Martin","year":"2005","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32838_bib80","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/ci034243x","article-title":"ESOL: estimating aqueous solubility directly from molecular structure","volume":"44","author":"Delaney","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32838_bib81","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/ci200387c","article-title":"Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area","volume":"52","author":"Ali","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.heliyon.2024.e32838_bib82","article-title":"SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in spirulina platensis","author":"Riyadi","year":"2021","journal-title":"Paper presented at the IOP Conference Series: Earth and Environmental Science"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib83","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.heliyon.2024.e32838_bib84","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"Int. Sch. Res. Notices"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e32838_bib85","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3390\/molecules24102006","article-title":"Multiclass classifier for P-glycoprotein substrates, inhibitors, and non-active compounds","volume":"24","author":"Mora Lagares","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e32838_bib86","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.33263\/BRIAC112.91269138","article-title":"Synthesis, spectral characterization, in vitro and in silico studies of benzodioxin pyrazoline derivatives","volume":"11","author":"Prabha","year":"2020","journal-title":"Biointerface Res Appl Chem"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32838_bib87","doi-asserted-by":"crossref","DOI":"10.1515\/psr-2018-0101","article-title":"Fundamental physical and chemical concepts behind \u201cdrug-likeness\u201d and \u201cnatural product-likeness\u201d","volume":"4","author":"Athar","year":"2019","journal-title":"Physical Sciences Reviews"},{"key":"10.1016\/j.heliyon.2024.e32838_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-1-8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J. Cheminf."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32838_bib89","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/cancers5020676","article-title":"Epigenetics and colorectal cancer pathogenesis","volume":"5","author":"Bardhan","year":"2013","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e32838_bib90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tim.2011.05.006","article-title":"Understanding the role of gut microbiome\u2013host metabolic signal disruption in health and disease","volume":"19","author":"Holmes","year":"2011","journal-title":"Trends Microbiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32838_bib91","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.chom.2015.05.016","article-title":"Bacteria moving into focus of human cancer","volume":"17","author":"Boccellato","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gastro\/gox031","article-title":"Dysbiosis of gut microbiota in promoting the development of colorectal cancer","volume":"6","author":"Zou","year":"2018","journal-title":"Gastroenterology report"},{"issue":"6141","key":"10.1016\/j.heliyon.2024.e32838_bib93","doi-asserted-by":"crossref","DOI":"10.1126\/science.1237439","article-title":"The long-term stability of the human gut microbiota","volume":"341","author":"Faith","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32838_bib94","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3748\/wjg.v22.i2.501","article-title":"Gut microbiota imbalance and colorectal cancer","volume":"22","author":"Gagni\u00e8re","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32838_bib95","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jmb.2019.12.003","article-title":"Good gone bad: one toxin away from disease for Bacteroides fragilis","volume":"432","author":"Valguarnera","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e32838_bib96","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fcimb.2019.00449","article-title":"Enterotoxigenic Bacteroides fragilis: a possible etiological candidate for bacterially-induced colorectal precancerous and cancerous lesions","volume":"9","author":"Zamani","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32838_bib97","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32838_bib98","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/CMR.00053-08","article-title":"Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes","volume":"22","author":"Sears","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib99","first-page":"3","article-title":"Peptide sequence region that is essential for the interactions of the enterotoxigenic Bacteroides fragilis metalloproteinase II with E-cadherin","volume":"1","author":"Shiryaev","year":"2014","journal-title":"Journal of proteolysis"},{"issue":"25","key":"10.1016\/j.heliyon.2024.e32838_bib100","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1073\/pnas.95.25.14979","article-title":"Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin","volume":"95","author":"Wu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2024.e32838_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.576559","article-title":"P-Glycoprotein: one mechanism, many tasks and the consequences for pharmacotherapy of cancers","volume":"10","author":"Seelig","year":"2020","journal-title":"Front. Oncol."},{"issue":"30","key":"10.1016\/j.heliyon.2024.e32838_bib102","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.3748\/wjg.v22.i30.6876","article-title":"Mechanisms of drug resistance in colon cancer and its therapeutic strategies","volume":"22","author":"Hu","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e32838_bib103","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fonc.2020.00265","article-title":"Perplexing role of P-glycoprotein in tumor microenvironment","volume":"10","author":"Robinson","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-55613-w","article-title":"Designing a multi-epitopic vaccine against the enterotoxigenic Bacteroides fragilis based on immunoinformatics approach","volume":"9","author":"Majid","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e32838_bib105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fcimb.2019.00364","article-title":"Drug discovery and repurposing inhibits a major gut pathogen-derived oncogenic toxin","volume":"9","author":"Metz","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47179-5","article-title":"Structure prediction, docking studies and molecular cloning of novel Pichia kudriavzevii YK46 metalloprotease (MetPr) for improvement of feather waste biodegradation","volume":"13","author":"Abd El-Aziz","year":"2023","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e32838_bib107","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e32838_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32838_bib109","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.heliyon.2024.e32838_bib110","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14502","article-title":"In vitro and in silico evaluations of actinomycin X2and actinomycin D as potent anti-tuberculosis agents","volume":"11","author":"Qureshi","year":"2023","journal-title":"PeerJ"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024088698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024088698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:56:07Z","timestamp":1790542567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024088698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":110,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024088698"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32838","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural products can be potential inhibitors of metalloproteinase II from Bacteroides fragilis to intervene colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e32838"}}